Zobrazeno 1 - 10
of 199
pro vyhledávání: '"V. P. Bondarev"'
Autor:
S. V. Shkodkin, M. Z. A. A. Zubaidi, V. P. Bondarev, M. B. Chibichyan, E. G. Ponomarev, V. Yu. Nechiporenko, K. S. Shkodkin
Publikováno v:
Vestnik Urologii, Vol 11, Iss 4, Pp 108-119 (2023)
Introduction. Nephron-sparing surgery for localised renal cell carcinoma has firmly entered the guideline base of all urological associations. One important aspect of this surgery is the management of the renal wound after partial nephrectomy. The ab
Externí odkaz:
https://doaj.org/article/9e47d75ee15c49d09ca73eb2791799ca
Publikováno v:
Биопрепараты: Профилактика, диагностика, лечение, Vol 23, Iss 3, Pp 262-274 (2023)
Scientific relevance. Botulinum toxin preparations are a good example of using a deadly toxin as a unique therapeutic agent. However, there are many unresolved issues related to biotechnology, biological activity, interchangeability, and standardisat
Externí odkaz:
https://doaj.org/article/10718c39e512411b964454b3e138cbb0
Publikováno v:
Биопрепараты: Профилактика, диагностика, лечение, Vol 23, Iss 1, Pp 7-25 (2023)
Vaccines are subject to specific regulatory requirements for the evaluation of their quality, safety, and efficacy. In 2005, the World Health Organisation (WHO), as the main international organisation coordinating measures to combat infectious diseas
Externí odkaz:
https://doaj.org/article/a6ada49ddbeb4215b4a68527cc963ec7
Publikováno v:
Биопрепараты: Профилактика, диагностика, лечение, Vol 22, Iss 4, Pp 361-381 (2022)
At the end of 2019, an outbreak of a new coronavirus began in the city of Wuhan (Hubei Province) in the People's Republic of China. The outbreak turned into a pandemic. In the shortest possible time, national and international manufacturers developed
Externí odkaz:
https://doaj.org/article/71abab0b199a458288cf212d295ce684
Autor:
L. V. Sayapina, N. A. Osina, E. A. Naryshkina, A. V. Fedorov, Ya. M. Krasnov, D. S. Davydov, V. P. Bondarev
Publikováno v:
Проблемы особо опасных инфекций, Vol 0, Iss 3, Pp 137-144 (2022)
The aim of the study was to improve the methods for verifying the vaccine strain Francisella tularensis 15 NIIEG during long-term storage under current conditions.Materials and methods. The paper summarizes the results of studying the phenotypic and
Externí odkaz:
https://doaj.org/article/017a04c334ce48958009196109ee916c
Publikováno v:
Биопрепараты: Профилактика, диагностика, лечение, Vol 22, Iss 2, Pp 218-225 (2022)
Reference standards for structure identification of recombinant therapeutic proteins are essential for quality assessment of recombinant protein-based biotechnological medicinal products. The development and certification of such reference standards
Externí odkaz:
https://doaj.org/article/63eaf08d48364d17b65b75efe5152f6a
Publikováno v:
Биопрепараты: Профилактика, диагностика, лечение, Vol 22, Iss 2, Pp 142-153 (2022)
Polioviruses belong to Enterovirus C species and cause severe lesions of the nervous system. In the post-polio eradication era, the World Health Organisation recommends inactivated polio vaccines for effective long-term protection of the population.
Externí odkaz:
https://doaj.org/article/54abbf9628014cdcb939fab1cff95a57
Autor:
M. V. Savkina, M. A. Krivykh, N. A. Gavrilova, L. V. Sayapina, Yu. I. Obukhov, V. A. Merkulov, V. P. Bondarev
Publikováno v:
Биопрепараты: Профилактика, диагностика, лечение, Vol 21, Iss 4, Pp 234-243 (2021)
Streptococcus pneumoniae infection is the most common cause of high morbidity and mortality among children under 5 years of age, immunocompromised people, and the elderly. Despite significant success, the approved pneumococcal conjugate and polysacch
Externí odkaz:
https://doaj.org/article/239591eac28a4ce684ca3b23f328254a
Autor:
N. A. Gavrilova, Yu. V. Olefir, V. A. Merkulov, V. P. Bondarev, E. M. Rychikhina, Yu. I. Obukhov
Publikováno v:
Биопрепараты: Профилактика, диагностика, лечение, Vol 21, Iss 3, Pp 142-157 (2021)
Vaccines by different manufacturers are available for most of the vaccine-preventable infections covered by the National Immunisation Schedule of the Russian Federation. Determination of the possibility of replacing a vaccine in the case of routine o
Externí odkaz:
https://doaj.org/article/e926f1ba330d471e95393bc70ae6fe50
Publikováno v:
Биопрепараты: Профилактика, диагностика, лечение, Vol 21, Iss 2, Pp 97-107 (2021)
Continuous replacement therapy with clotting factor products can lead to serious complications in haemophilia A patients. One of potential reasons of such complications is an undesirable immune response to a blood clotting factor VIII (FVIII) product
Externí odkaz:
https://doaj.org/article/4199322630aa482794e8c5c50a39311e